4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-025155
Senior VP - CMO sold 62,500 shares at $7.03 ($439,375)
- Senior VP - CMO acquired 62,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sheridan William P Senior VP - CMO | 2018-08-09 | Option exercise | +62,500 | $1.42 | $88,750 | 85,713 | D: show line 1 in the form |
| Sheridan William P Senior VP - CMO | 2018-08-09 | Sale | −62,500 | $7.03 | $439,375 | 23,213 | D: show line 2 in the form |
| Open-market sales · 62,500 sh · avg $7.03 · $439,375 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sheridan William P Senior VP - CMO | 2018-08-09 | Option exercise · Emp. Stock Option (Right to Buy) | −62,500 | 0 | D: show line 3 in the form |
Loading xslF345X03/form4.xml…